Gabriel Paijo 
Billy Candra 
admin 
Lina carolina 
Nana O Scientists Develop Novel Antibody Targeting SFRP2 to Combat Triple Negative Breast Cancer and Overcome Treatment Resistance
Researchers at the MUSC Hollings Cancer Center have announced a significant breakthrough in the treatment...
Combination of Niraparib and Abiraterone Significantly Delays Progression in Advanced Prostate Cancer Patients with Specific Genetic Mutations.
A landmark international study spearheaded by researchers at University College London (UCL) has unveiled a...
Building the Data-First Future of Immunotherapy
For over 70 years, the Cancer Research Institute (CRI) has stood at the vanguard of...
A Promising New Combination Therapy Shows Potential to Significantly Extend Survival for Glioblastoma Patients
A groundbreaking study spearheaded by researchers at Keck Medicine of USC has unveiled a potent...
The Silent Indicator: Why Your Neck Circumference Might Be a Crucial Marker for Chronic Disease Risk
For decades, the medical community has relied on established metrics like body mass index (BMI)...
Soot-Like Carbon Deposits Accumulate at Higher Levels in Lungs of COPD Patients, New Study Reveals
Cells meticulously collected from the lungs of individuals diagnosed with chronic obstructive pulmonary disease (COPD)...
A Novel Nasal Nanotherapy Promises a Noninvasive Breakthrough Against Glioblastoma
Researchers at Washington University School of Medicine in St. Louis, collaborating with scientists at Northwestern...
UVA Health Researchers Uncover Critical Immune Defense Mechanism Against Brain-Infecting Parasite Toxoplasma gondii
Suherman Candra Maholtra A groundbreaking study led by researchers at the University of Virginia School of Medicine has...
Biopharma Sector Buzzes with Strategic Approvals, Key Partnerships, and Market Reactions Across Global Health Landscapes
The biopharmaceutical industry is currently a hotbed of activity, marked by significant regulatory milestones, innovative...
Roche’s Amylin-Targeting Obesity Drug Petrelintide Underperforms in Phase 2, Raising Questions on Market Competitiveness
Basel, Switzerland – Hopes for Roche’s amylin-targeting obesity drug, petrelintide, have been tempered following the...